Ozempic injection pen does not have one price that every patient pays. As checked October 4, 2026, official self-pay programs list $349 or $499 per 28-day program fill, depending on the prescribed pen. The $199 introductory offer applies to the first two eligible fills of a specific pen, with separate eligibility and deadline rules. NovoCare pharmacy terms, savings card terms.
This guide covers Ozempic injection pens in the U.S. Official savings pages also discuss pills, and the injection label lists prefilled syringes. The pen-program prices below should not be transferred to a different formulation or presentation. Ozempic savings information, injection prescribing information, revised May 2026, section 3.
Ozempic injection is FDA approved for specified uses in adults with type 2 diabetes; it is not FDA approved for weight management. This guide does not promise insurance coverage for off-label use. Ozempic injection label, section 1.
Ozempic cost routes at a glance
These are published program amounts, not a quote for your prescription. Use the official pen price guide, dated May 2026 and checked October 4, to identify the program relevant to your prescribed pen.
| Payment route | Published amount | What determines your actual cost |
|---|---|---|
| Introductory pen self-pay offer | $199 for each of the first two eligible 28-day fills | Only the specified introductory pen; new-patient definitions and deadlines differ by channel |
| Standard pen self-pay program | $349 or $499 per 28-day program fill | Exact prescribed pen and current program eligibility; the price table defines one box containing one pen |
| Commercial coverage plus an eligible savings card | As little as $25 for an applicable prescription | Coverage, enrollment and card eligibility; maximum manufacturer savings apply |
| Insurance without an applicable manufacturer offer | No universal patient price | Your plan's coverage, cost-sharing, deductible and authorization decision |
| Pharmacy retail cash purchase outside a program | Obtain a written pharmacy quote | Exact product, quantity, pharmacy and any separate fees |
Sources: NovoCare pharmacy terms, savings card terms, and NovoCare price explanation. A 28-day program fill is not a calendar month. Confirm the supply period rather than assuming every advertised monthly price covers the same time.
What happens after the $199 introductory fills?
The standard self-pay price applies after the eligible introductory fills: $349 or $499 per program fill, depending on the pen prescribed. The introductory amount does not apply to every pen. Do not select a prescription or change treatment to fit a price; ask your prescriber about treatment and your pharmacy about the matching offer. NovoCare pharmacy terms.
Keep these two channels separate when confirming the introductory offer:
| Channel | Meaning of “new” in the checked terms | Introductory deadline |
|---|---|---|
| Retail pharmacy savings offer | New to the Ozempic Savings Offer, with no participation in prior Ozempic savings offers in the past 365 days | Offer redeemed and prescription filled by December 31, 2026 |
| Direct NovoCare Pharmacy program | Never previously filled an Ozempic injection prescription through NovoCare or NovoCare Legacy | Prescription written and received by the pharmacy by December 31, 2026; shipment by January 31, 2027 |
Sources: retail savings terms, direct pharmacy terms, checked October 4, 2026. A first prescription does not by itself answer every program eligibility question. Ask the dispensing pharmacy which channel it is using and whether you qualify.
How commercial insurance savings work
The covered-commercial offer requires commercial prescription coverage, a valid prescription for a labeled indication, enrollment and current eligibility. Its “as little as $25” wording is conditional. Maximum manufacturer savings are $100 for a one-month prescription, $200 for two months and $300 for three months; an injection month is defined as 28 days. These limits can leave more than $25 to pay. Full savings card terms.
The card describes eligibility for up to 48 months after enrollment, subject to the manufacturer's ability to change or end the offer. That is not a price lock. The December 31, 2026 deadline above belongs to the introductory offer, rather than the entire card. Savings card terms.
Medicare, Medicaid, VA, Department of Defense, TRICARE and similar government prescription coverage are excluded from the commercial copay offer. Certain other plans and assistance arrangements have additional rules in the full terms. Ask your insurer whether this exact prescription is covered, whether authorization is required or approved, and what you owe after applicable assistance. Savings eligibility terms.
If you are uninsured or have government coverage
The direct pharmacy's eligible self-pay route operates outside insurance. Its terms permit eligible government-insured patients to choose self-pay, so the commercial-card exclusion should not be treated as an exclusion from every cash program. Self-pay purchases cannot be submitted for reimbursement or counted toward an insurance deductible or out-of-pocket spending requirement. NovoCare pharmacy terms, Ozempic savings FAQs.
For Ozempic in 2026, NovoCare's patient assistance program sets an income threshold of no more than 200% of the federal poverty level for qualifying uninsured applicants. Citizenship or residency, government-program status and application requirements also apply. Commercially insured patients are ineligible; Medicare beneficiaries with prescription coverage are also ineligible for Ozempic assistance through this program. Free medicine depends on qualification, not merely submitting an application. Product-specific patient assistance requirements.
Why list price is a different number
Manufacturer list price is distinct from a pharmacy cash quote, insured copay or self-pay program price. The official list-price page contained inconsistent amounts when checked October 4, so this guide does not present one as a confirmed current figure. Confirm it with the manufacturer if you need that benchmark; confirm your personal amount with the pharmacy. NovoCare list-price explanation.
Novo Nordisk has announced a $675 list price effective January 1, 2027. That is a future list-price change, not the October 2026 patient price or a guaranteed future copay. The announcement says direct-to-patient self-pay prices do not change as a result. Manufacturer announcement, February 24, 2026.
Get a written quote for this fill and the next
Ask the dispensing pharmacy to date a quote with these fields. Keep it in your private records.
| Field | What to confirm |
|---|---|
| Exact prescription | Product and prescribed pen, product code, box count and days supplied |
| Payment route | Insurance, commercial card, direct pharmacy self-pay or another cash purchase |
| Eligibility and authorization | Offer eligibility, introductory fills remaining, and any unresolved plan authorization |
| First and next totals | Amount due now and expected amount for the next fill, with assumptions and deadlines |
| Separate charges | Taxes, shipping, supplies and any separately billed clinician or service fees |
| Insurance accounting | Whether spending counts toward the deductible or out-of-pocket requirement under the applicable terms |
A medication offer is not a total care budget. Compare matching quantities and supply periods, and include any separate care charges. Recheck program terms before filling. For another example of this quote method, see the Zepbound cost worksheet. For insurance questions involving Medicare, see Medicare and GLP-1 coverage.
Educational information only. Program eligibility does not establish clinical suitability or guarantee a prescription, coverage, supply or final price. Discuss treatment decisions with your licensed prescriber.
Frequently Asked Questions
How much does Ozempic cost without insurance?
As checked October 4, 2026, official injection pen self-pay pricing is $349 or $499 per 28-day program fill, depending on the prescribed pen. The $199 introductory offer covers each of the first two eligible fills of a specific pen, with channel-specific eligibility and deadlines. Ask the pharmacy for your actual first and next totals.
Does the $199 Ozempic price apply to every pen or refill?
No. As checked October 4, 2026, it applies to the specified introductory pen and at most the first two eligible fills. New-patient rules and deadlines differ between the retail savings offer and direct NovoCare Pharmacy program. Standard self-pay pricing applies afterward. See the full program terms.
Is the $25 commercial insurance price guaranteed?
No. As checked October 4, 2026, the offer says as little as $25. Commercial coverage, enrollment, prescription eligibility and maximum savings determine the actual amount due. Confirm it with the dispensing pharmacy.
Can Medicare beneficiaries use Ozempic savings programs?
They are excluded from the commercial copay card offer. Eligible government-insured patients may choose the direct pharmacy self-pay route outside insurance, without reimbursement or deductible credit. Medicare beneficiaries with prescription coverage are ineligible for Ozempic through the patient assistance program. Check the separate terms for each route.
Is the announced $675 Ozempic list price the current cash price?
No. As checked October 4, 2026, Novo Nordisk announced that list price for January 1, 2027. It is not the October 2026 patient price or a guaranteed future copay. The announcement says direct-to-patient self-pay prices do not change as a result.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Ozempic cost and insurance coverage; live pen and pill savings information checked October 4, 2026 · Novo Nordisk · accessed
- 2.NovoCare diabetes savings card full terms; live eligibility, commercial and self-pay conditions checked October 4, 2026 · Novo Nordisk · accessed
- 3.NovoCare Pharmacy full terms; live Ozempic pen prices, supply definitions and introductory rules checked October 4, 2026 · Novo Nordisk · accessed
- 4.Ozempic Price Guide, May 2026, document US26NC00009; live PDF checked October 4, 2026 · Novo Nordisk · accessed
- 5.NovoCare explanation of list price; live page contained inconsistent list-price amounts when checked October 4, 2026 · Novo Nordisk · accessed
- 6.NovoCare patient assistance program, product-specific Ozempic eligibility for 2026 · Novo Nordisk · accessed
- 7.Manufacturer list-price announcement, February 24, 2026, effective January 1, 2027 · Novo Nordisk · accessed
- 8.Ozempic injection U.S. prescribing information, revised May 2026; section 3 · Novo Nordisk · accessed
Telehealth prescribing rules differ by state. Read the state-by-state guide.
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them